Revenue
2016
2017
2018
2019
2020
2022
2023
2024
Ernexa Therapeutics Inc. (ERNA)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $582,000 | $68,000 | $0 | — | $5.8M | $19.8M | $23.3M | $21.3M | $22.3M | $24.5M | $26.0M | $23.7M | $24.1M | $23.9M | $25.3M |
| Gross profit | — | $486,000 | −$168,000 | $0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $4.2M | $4.6M | $5.9M | $10.4M | $12.7M | $4.0M | $26,000 | $72,000 | $139,000 | — | — | — | — | — | — | — |
| Operating expenses | $9.3M | $16.2M | $21.0M | $33.2M | $113.7M | $7.2M | $21.6M | $23.1M | $22.7M | $24.6M | $31.4M | $30.8M | $24.9M | $25.1M | $27.1M | $25.6M |
| Operating income | −$9.3M | −$15.7M | −$21.1M | −$33.2M | −$113.7M | −$7.2M | −$1.8M | $203,000 | −$1.4M | −$2.3M | −$6.9M | −$4.7M | −$1.1M | −$1.1M | −$3.3M | −$325,000 |
| EBITDAderived | −$9.3M | −$15.5M | −$21.1M | −$33.1M | −$113.6M | −$7.2M | $1.1M | $3.0M | $915,000 | $609,000 | −$3.8M | −$2.0M | $1.7M | $1.8M | −$16,000 | $2.9M |
| Net income | −$14.1M | −$44.5M | −$21.7M | −$24.6M | −$122.5M | −$7.3M | −$2.0M | −$259,000 | −$1.1M | −$2.9M | −$7.2M | −$5.0M | −$1.1M | −$995,000 | −$3.4M | −$400,000 |
| Basic EPSper diluted share | -$2.24 | -$48.96 | -$4.08 | -$8.06 | -$56.61 | -$0.41 | -$0.72 | -$0.10 | -$0.45 | -$1.54 | -$3.93 | -$0.06 | -$0.01 | -$0.01 | -$0.06 | -$0.01 |
| Diluted EPSper diluted share | -$2.24 | -$48.96 | -$4.08 | -$8.06 | -$56.61 | -$0.41 | -$0.72 | -$0.10 | -$0.45 | -$1.54 | -$3.93 | -$0.06 | -$0.01 | -$0.01 | -$0.06 | -$0.01 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 10, 2026Form 4 | Cherington CharlesTenPercentOwner | BuyCommon Stock | 4.00M | $0.50 | $2.00M | 6.78M |
| Feb 10, 2026Form 4 | Cherington CharlesTenPercentOwner | BuyWarrants to Purchase Common Stock · derivative | 4.00M | — | — | 4.00M |
| Jun 9, 2025Form 4 | Cherington CharlesTenPercentOwner | BuyCommon Stock | 21.24M | $0.10 | $2.12M | 41.66M |
| Apr 2, 2025Form 4 | Cherington CharlesTenPercentOwner | BuyCommon Stock | 3.77M | $0.10 | $376.8K | 20.40M |
| Oct 29, 2024Form 4 | Cherington CharlesTenPercentOwner | BuyCommon Stock | 1.56M | — | — | 13.81M |